1. Home
  2. Browse
  3. Cancer

75 open

Cancer funding

75 open opportunities tagged Cancer, across federal agencies and private foundations. Sorted by deadline.

PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)

RFA-RM-27-012National Institutes of Health3 review criteria on file

—

Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

RFA-CA-27-021National Institutes of Health8 review criteria on fileagency framework

$600k

Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

RFA-CA-27-020National Institutes of Health8 review criteria on file

$600k

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

RFA-CA-27-019National Institutes of Health4 review criteria on file

$300k

NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)

PAR-25-271National Institutes of Health3 review criteria on file

—

NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)

PAR-25-269National Institutes of Health3 review criteria on file

$350k

NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)

PAR-25-270National Institutes of Health3 review criteria on file

$1.1M

HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

RFA-NS-27-007National Institutes of Health3 review criteria on file

—

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

PAR-25-104National Institutes of Health4 review criteria on file

—

Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)

PAR-25-299National Institutes of Health3 review criteria on fileagency framework

—

Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)

PAR-25-043National Institutes of Health3 review criteria on file

$500k

Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)

PAR-24-311National Institutes of Health3 review criteria on file

$500k

Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

PA-25-172National Institutes of Health3 review criteria on fileagency framework

—

NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)

PAR-27-058National Institutes of Health4 review criteria on fileagency framework

$500k

Causal Hypotheses on the Oral-Systemic Health Impacts of Human Behaviors among People with Chronic Conditions (U01 Clinical Trial Not Allowed)

PAR-27-057National Institutes of Health3 review criteria on fileagency framework

$500k

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

PAR-25-069National Institutes of Health3 review criteria on file

—

Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)

PAR-27-073National Institutes of Health3 review criteria on file

—

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

PAR-25-175National Institutes of Health3 review criteria on fileagency framework

$500k

Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)

PAR-25-243National Institutes of Health3 review criteria on fileagency framework

—

Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)

PAR-25-098National Institutes of Health3 review criteria on file

—

The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)

PAR-26-134National Institutes of Health3 review criteria on file

$500k

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

PAR-25-079National Institutes of Health3 review criteria on fileagency framework

$500k

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

PAR-25-081National Institutes of Health4 review criteria on fileagency framework

$500k

Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)

PAR-27-072National Institutes of Health3 review criteria on file

$500k

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

PAR-25-167National Institutes of Health3 review criteria on file

—

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

PAR-25-095National Institutes of Health3 review criteria on file

$350k

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

RFA-CA-27-001National Institutes of Health4 review criteria on file

$150k

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

RFA-CA-27-002National Institutes of Health4 review criteria on fileagency framework

$300k

Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Not Allowed)

PAR-27-025National Institutes of Health7 review criteria on fileagency framework

—

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

PA-25-253National Institutes of Health3 review criteria on fileagency framework

—

Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)

PAR-25-044National Institutes of Health3 review criteria on file

—

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

PAR-25-070National Institutes of Health3 review criteria on file

—

Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)

PAR-25-336National Institutes of Health4 review criteria on file

—

Community-Based Participatory Research to Advance Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All (UG3/UH3 Clinical Trial Optional)

PAR-27-015National Institutes of Health3 review criteria on file

$300k

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)

PAR-25-244National Institutes of Health3 review criteria on file

—

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)

PAR-25-346National Institutes of Health3 review criteria on file

—

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

PAR-25-096National Institutes of Health3 review criteria on file

$200k

DoW Rare Cancers Resource and Community Development Award

HT942526RCRPRCDADefense Health Agency Contracting Activity - DHACAReview criteria on file

—

DoW Breast Cancer, Breakthrough Award Levels 1 and 2

HT942526BCRPBTA122Defense Health Agency Contracting Activity - DHACA

—

DoW Rare Cancers Idea Development Award

HT942526RCRPIDADefense Health Agency Contracting Activity - DHACAReview criteria on file

—

DoW Breast Cancer, Clinical Research Extension Award

HT942526BCRPCREA2Defense Health Agency Contracting Activity - DHACA

—

Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)

PAR-25-221National Institutes of Health3 review criteria on file

—

Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)

PAR-27-071National Institutes of Health7 review criteria on file

—

Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)

RFA-CA-27-005National Institutes of Health

$700k

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

PAR-25-444National Institutes of Health11 review criteria on fileagency framework

—

Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional)

PAR-28-062National Institutes of Health

—

Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)

RFA-OD-25-010National Institutes of Health7 review criteria on fileagency framework

—

Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)

RFA-OD-25-011National Institutes of Health9 review criteria on fileagency framework

—

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

PAR-25-325National Institutes of Health3 review criteria on file

—

Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)

RFA-CA-28-013National Institutes of Health

$700k

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

PAR-25-248National Institutes of Health3 review criteria on file

—

Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)

RFA-CA-28-004National Institutes of Health

—

Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)

PAR-28-057National Institutes of Health

$500k

INCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed)

RFA-OD-27-004National Institutes of Health3 review criteria on fileagency framework

$500k

INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required)

RFA-OD-27-005National Institutes of Health3 review criteria on fileagency framework

—

INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed)

RFA-OD-27-003National Institutes of Health3 review criteria on fileagency framework

$200k

Department of Defense HIV/AIDS Prevention Program

W81XWH-22-DHAPPDefense Health Agency Contracting Activity - DHACAReview criteria on file

—

Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)

PAR-25-103National Institutes of Health4 review criteria on file

—

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

PAR-25-145National Institutes of Health3 review criteria on fileagency framework

—

Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)

PAR-25-324National Institutes of Health1 review criteria on fileagency framework

—

Showing 60 of 75.

Read the review criteria before you apply

A free account shows the review criteria on file and the announcement text where we hold it. The eligibility check, funded precedents and the Reviewer Scorecard are on Plus, $39 a month. No card required.

Create free accountBrowse all funders

Related subjects